Ubs Group Ag Incyte Corp Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Incyte Corp stock. As of the latest transaction made, Ubs Group Ag holds 1,455,682 shares of INCY stock, worth $152 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,455,682

Previous 1,361,182 6.94%

Holding current value

$152 Million

Previous $92.7 Million 33.18%

% of portfolio

0.02%

Previous 0.02%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$67.27 - $86.96 $6.36 Million - $8.22 Million	94,500 Added 6.94%	1,455,682 $123 Million
Q2 2025 Aug 14, 2025	BUY	$55.17 - $71.22 $2 Million - $2.59 Million	36,326 Added 2.74%	1,361,182 $92.7 Million
Q1 2025 May 13, 2025	BUY	$60.0 - $75.26 $30.9 Million - $38.7 Million	514,187 Added 63.43%	1,324,856 $80.2 Million
Q4 2024 Feb 14, 2025	BUY	$65.08 - $83.38 $20 Million - $25.6 Million	307,623 Added 61.15%	810,669 $56 Million
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $2.99 Million - $3.58 Million	52,193 Added 11.58%	503,046 $33.3 Million

Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $2.39 Million - $2.98 Million	46,741 Added 11.57%	450,853 $27.3 Million
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $6.67 Million - $7.85 Million	-117,959 Reduced 22.59%	404,112 $23 Million
Q4 2023 Feb 09, 2024	BUY	$52.16 - $64.19 $6.72 Million - $8.27 Million	128,859 Added 32.77%	522,071 $32.8 Million
Q3 2023 Nov 09, 2023	SELL	$57.77 - $65.93 $5.42 Million - $6.19 Million	-93,846 Reduced 19.27%	393,212 $22.7 Million
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $16.5 Million - $20.5 Million	270,989 Added 125.42%	487,058 $30.3 Million
Q1 2023 May 12, 2023	SELL	$70.23 - $86.01 $17.7 Million - $21.7 Million	-251,834 Reduced 53.82%	216,069 $15.6 Million
Q4 2022 Feb 08, 2023	SELL	$67.18 - $84.11 $2.99 Million - $3.74 Million	-44,454 Reduced 8.68%	467,903 $37.6 Million
Q3 2022 Nov 10, 2022	SELL	$66.18 - $82.86 $3.97 Million - $4.97 Million	-59,969 Reduced 10.48%	512,357 $34.1 Million
Q2 2022 Aug 10, 2022	SELL	$66.18 - $83.18 $156 Million - $197 Million	-2,364,263 Reduced 80.51%	572,326 $43.5 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $130 Million - $157 Million	1,973,236 Added 204.83%	2,936,589 $233 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $45.8 Million - $53.5 Million	722,522 Added 300.01%	963,353 $70.7 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $6.08 Million - $7.44 Million	88,590 Added 58.19%	240,831 $16.6 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $105,827 - $115,977	1,325 Added 0.88%	152,241 $12.8 Million
Q1 2021 May 12, 2021	SELL	$76.02 - $100.5 $5.72 Million - $7.56 Million	-75,197 Reduced 33.26%	150,916 $12.3 Million
Q4 2020 Feb 11, 2021	BUY	$80.74 - $97.7 $8.37 Million - $10.1 Million	103,609 Added 84.58%	226,113 $19.7 Million
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $6.05 Million - $7.8 Million	-71,098 Reduced 36.72%	122,504 $11 Million
Q2 2020 Jul 31, 2020	BUY	$74.18 - $108.93 $4.57 Million - $6.71 Million	61,572 Added 46.63%	193,602 $20.1 Million
Q1 2020 May 01, 2020	SELL	$63.18 - $85.97 $3.43 Million - $4.67 Million	-54,355 Reduced 29.16%	132,030 $9.67 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $4.93 Million - $6.47 Million	-67,555 Reduced 26.6%	186,385 $16.3 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $3.93 Million - $4.67 Million	53,983 Added 27.0%	253,940 $18.9 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $922,676 - $1.11 Million	-12,550 Reduced 5.91%	199,957 $17 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $318,054 - $441,202	5,004 Added 2.41%	212,507 $18.3 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $102 Million - $122 Million	-1,746,528 Reduced 89.38%	207,503 $13.2 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $161 Million - $194 Million	-2,606,972 Reduced 57.16%	1,954,031 $135 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $265 Million - $365 Million	4,348,199 Added 2043.29%	4,561,003 $306 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $3.25 Million - $3.95 Million	-39,129 Reduced 15.53%	212,804 $17.7 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $2.6 Million - $3.24 Million	-27,778 Reduced 9.93%	251,933 $23.9 Million
Q3 2017 Nov 14, 2017	SELL	$109.15 - $138.27 $2.46 Million - $3.12 Million	-22,578 Reduced 7.47%	279,711 $32.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,939 Added 7.83%	302,289 $38.1 Million
Q1 2017 Nov 14, 2017	BUY	N/A	280,350	280,350 $37.5 Million

Others Institutions Holding INCY

# of Institutions

795

Shares Held

205M

Call Options Held

638K

Put Options Held

635K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $23.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account